14th World Antibody-Drug Conjugate Event (ADC), London, March 2024

Glymab® ADC’s for targeting cancers with high unmet need Fucosyl-GM1 and LewisY : internalising targets for SCLC and multiple solid tumours

Bryony Heath, Elena Dubinina, Foram Dave, Ruhul H. Choudhury, Omar Mohammed, Bubacarr Kaira, Poonam Vaghela, Tina Parsons, Mandeep Sehmi, Mireille Vankemmelbeke and Lindy G. Durrant

Comments

Comments are closed on this post.